{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T12:10:03Z","timestamp":1780920603981,"version":"3.54.1"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T00:00:00Z","timestamp":1773100800000},"content-version":"vor","delay-in-days":68,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Treatment and Research Communications"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/j.ctarc.2026.101175","type":"journal-article","created":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T16:29:45Z","timestamp":1773246585000},"page":"101175","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Association between biochemical and histopathological parameters in the clinical assessment of prostate tumors in a resource-limited setting in northern Cameroon"],"prefix":"10.1016","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4903-0625","authenticated-orcid":false,"given":"Richard","family":"Tagne Simo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larissa P\u00e9lagie","family":"Nodjia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armel Herv\u00e9","family":"Nwabo Kamdje","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamadou","family":"Ahmadou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franklin","family":"Danki Sillong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phelix Bruno","family":"Telefo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ctarc.2026.101175_bib0001","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0153496","article-title":"An estimate of the incidence of prostate cancer in Africa: a systematic review and meta-analysis","volume":"11","author":"Adeloye","year":"2016","journal-title":"PLoS. One"},{"key":"10.1016\/j.ctarc.2026.101175_bib0002","doi-asserted-by":"crossref","first-page":"63","DOI":"10.14740\/wjon1191","article-title":"Epidemiology of prostate cancer","volume":"10","author":"Rawla","year":"2019","journal-title":"World J. Oncol."},{"key":"10.1016\/j.ctarc.2026.101175_bib0003","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1186\/1750-9378-6-S2-S5","article-title":"Impact of health system challenges on prostate cancer control: health care experiences in Nigeria","volume":"6","author":"Ogunbiyi","year":"2011","journal-title":"Infect. Agent. Cancer"},{"key":"10.1016\/j.ctarc.2026.101175_bib0004","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1093\/oxfordjournals.epirev.a000787","article-title":"Impact of screening on incidence and mortality of prostate cancer in the United States","volume":"23","author":"Potosky","year":"2001","journal-title":"Epidemiol. Rev."},{"key":"10.1016\/j.ctarc.2026.101175_bib0005","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.purol.2008.10.008","article-title":"Epidemiology and histopronostic of prostatic cancer in Togo: about 202 cases diagnosed at the laboratory of pathology of the Tokoin teaching hospital of Lome]","volume":"19","author":"Am\u00e9gbor","year":"2009","journal-title":"Prog. Urol."},{"key":"10.1016\/j.ctarc.2026.101175_bib0006","first-page":"58","article-title":"Current cancer incidence and trends in Yaounde","volume":"1","author":"Orock","year":"2012","journal-title":"Cameroon. OGH Rep."},{"key":"10.1016\/j.ctarc.2026.101175_bib0007","doi-asserted-by":"crossref","first-page":"67","DOI":"10.11604\/pamj.2016.23.67.8170","article-title":"The profile of patients with obstructive Uropathy in Cameroon: case of the Douala general hospital","volume":"23","author":"Halle","year":"2016","journal-title":"Pan. Afr. Med. J."},{"key":"10.1016\/j.ctarc.2026.101175_bib0008","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1158\/1078-0432.CCR-23-3083","article-title":"Impact of circulating tumor cell\u2013expressed prostate-specific membrane antigen and prostate-specific antigen transcripts in different stages of prostate cancer","volume":"30","author":"Cho","year":"2024","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ctarc.2026.101175_bib0009","doi-asserted-by":"crossref","DOI":"10.1177\/10732748221081366","article-title":"Determination of serum prostate specific antigen levels amongst apparently healthy Nigerian males in a university and university hospital community in the federal capital territory","volume":"29","author":"Aisuodionoe-Shadrach","year":"2022","journal-title":"Cancer Control"},{"key":"10.1016\/j.ctarc.2026.101175_bib0010","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jobcr.2020.02.004","article-title":"Age and gender characteristics of the biochemical composition of saliva: correlations with the composition of blood plasma","volume":"10","author":"Bel\u2019skaya","year":"2020","journal-title":"J. Oral Biol. Craniofacial Res."},{"issue":"6","key":"10.1016\/j.ctarc.2026.101175_bib0011","article-title":"Reference Values for Serum Creatinine with Jaffe-compensated Assay in Adult Iranian Subjects: Tehran Lipid and Glucose Study","volume":"17","author":"Ghasemi","year":"2014","journal-title":"Arch. Iran Med."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101175_bib0012","first-page":"10","article-title":"Cancer statistics","volume":"75","author":"Siegel","year":"2025","journal-title":"CA Canc. J. Clin."},{"issue":"2","key":"10.1016\/j.ctarc.2026.101175_bib0013","doi-asserted-by":"crossref","first-page":"91","DOI":"10.15430\/JCP.2019.24.2.91","article-title":"Occupational Risk Factors for Prostate Cancer: A Meta-analysis","volume":"24","author":"Krstev","year":"2019","journal-title":"J. Canc. Prev."},{"issue":"4","key":"10.1016\/j.ctarc.2026.101175_bib0014","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.eururo.2005.06.001","article-title":"EAU Guidelines on Prostate Cancer","volume":"48","author":"Aus","year":"2005","journal-title":"Europ. Urol."},{"key":"10.1016\/j.ctarc.2026.101175_bib0015","unstructured":"S.D. Lokeshwar, B.T. Harper, E. Webb, A. Jordan, T.A. Dykes, D.E. Neal, M.K. Terris, Z. Klaassen, Epidemiology and treatment modalities for the management of benign prostatic hyperplasia, Transl. Androl. Urol., doi:8201952953910.21037\/tau.2019.10.01."},{"issue":"2","key":"10.1016\/j.ctarc.2026.101175_bib0016","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/S0022-5347(05)00162-X","article-title":"Obesity, Serum Prostate Specific Antigen and Prostate Size: Implications for Prostate Cancer Detection","volume":"175","author":"Freedland","year":"2006","journal-title":"J. Urol."},{"key":"10.1016\/j.ctarc.2026.101175_bib0017","unstructured":"F.H. Schr\u00f6der, J. Hugosson, M.J. Roobol, T.L.J. Tammela, M. Zappa, V. Nelen, M. Kwiatkowski, M. Lujan, L. M\u00e4\u00e4tt\u00e4nen, H. Lilja, L.J. Denis, F. Recker, A. Paez, C.H. Bangma, S. Carlsson, D. Puliti, A. Villers, X. Rebillard, M. Hakama, U.H. Stenman, P. Kujala, K. Taari, G. Aus, A. Huber, Kwast T.H. van der, R.H.N.van Schaik, H.J.de Koning, S.M. Moss, A. Auvinen, Screening and prostate cancer mortality: results of the European randomised study of screening for prostate cancer (ERSPC) at 13 years of follow-up, Lancet, doi:38420142027203510.1016\/S0140-6736(14)60525-0."},{"issue":"3","key":"10.1016\/j.ctarc.2026.101175_bib0018","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.amepre.2013.04.015","article-title":"Prostate-Specific Antigen and Prostate Cancer Mortality: A Systematic Review","volume":"45","author":"Wallner","year":"2013","journal-title":"Amer. J. Prev. Medic."},{"issue":"2","key":"10.1016\/j.ctarc.2026.101175_bib0019","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1053\/snep.2001.20942","article-title":"Urinary tract obstruction","volume":"21","author":"Klahr","year":"2001","journal-title":"Sem. Nephrol."},{"issue":"5","key":"10.1016\/j.ctarc.2026.101175_bib0020","doi-asserted-by":"crossref","first-page":"705","DOI":"10.3390\/jpm13050705","article-title":"Biomarkers for Prostate Cancer Bone Metastasis Detection and Prediction","volume":"13","author":"Ying","year":"2023","journal-title":"J. Pers. Med."}],"container-title":["Cancer Treatment and Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468294226000869?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468294226000869?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T11:37:52Z","timestamp":1780918672000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468294226000869"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":20,"alternative-id":["S2468294226000869"],"URL":"https:\/\/doi.org\/10.1016\/j.ctarc.2026.101175","relation":{},"ISSN":["2468-2942"],"issn-type":[{"value":"2468-2942","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association between biochemical and histopathological parameters in the clinical assessment of prostate tumors in a resource-limited setting in northern Cameroon","name":"articletitle","label":"Article Title"},{"value":"Cancer Treatment and Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctarc.2026.101175","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101175"}}